EP1011440A4 - Vaccine against lipopolysaccharide core - Google Patents

Vaccine against lipopolysaccharide core

Info

Publication number
EP1011440A4
EP1011440A4 EP98922339A EP98922339A EP1011440A4 EP 1011440 A4 EP1011440 A4 EP 1011440A4 EP 98922339 A EP98922339 A EP 98922339A EP 98922339 A EP98922339 A EP 98922339A EP 1011440 A4 EP1011440 A4 EP 1011440A4
Authority
EP
European Patent Office
Prior art keywords
vaccine against
against lipopolysaccharide
lipopolysaccharide core
core
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98922339A
Other languages
German (de)
French (fr)
Other versions
EP1011440A1 (en
Inventor
Elliott Bennett-Guerrero
George Robin Barclay
Ian Raymond Poxton
Thomas James Mcintosh
David Scott Snyder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Defence Technologies LLC
Original Assignee
Medical Defence Technologies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Defence Technologies LLC filed Critical Medical Defence Technologies LLC
Publication of EP1011440A1 publication Critical patent/EP1011440A1/en
Publication of EP1011440A4 publication Critical patent/EP1011440A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
EP98922339A 1997-05-16 1998-05-15 Vaccine against lipopolysaccharide core Withdrawn EP1011440A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4668097P 1997-05-16 1997-05-16
US46680P 1997-05-16
PCT/US1998/009988 WO1998051217A1 (en) 1997-05-16 1998-05-15 Vaccine against lipopolysaccharide core

Publications (2)

Publication Number Publication Date
EP1011440A1 EP1011440A1 (en) 2000-06-28
EP1011440A4 true EP1011440A4 (en) 2003-08-06

Family

ID=21944797

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98922339A Withdrawn EP1011440A4 (en) 1997-05-16 1998-05-15 Vaccine against lipopolysaccharide core

Country Status (5)

Country Link
EP (1) EP1011440A4 (en)
JP (1) JP2001527562A (en)
AU (1) AU7491298A (en)
CA (1) CA2289760A1 (en)
WO (1) WO1998051217A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20085812A0 (en) * 2008-09-01 2008-09-01 Esa-Matti Lilius Rough LPS as immunostimulant in aqueous culture
WO2012171077A1 (en) * 2011-06-17 2012-12-20 Immuron Limited Method and composition for treatment or inhibition of mucositis associated with chemotherapy or radiation damage
US11186652B2 (en) 2015-12-22 2021-11-30 Glaxosmithkline Biologicals Sa LPS extraction process
FR3072880A1 (en) 2017-10-30 2019-05-03 Institut National De La Sante Et De La Recherche Medicale (Inserm) LIPOSOMAL FORMULATION AND USE THEREOF IN ANTI-TUMOR THERAPY

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995029662A2 (en) * 1994-04-20 1995-11-09 U.S. Department Of The Army Vaccine against gram-negative bacterial infections
WO1996025146A1 (en) * 1995-02-16 1996-08-22 Novavax, Inc. Gram negative bacterial infection vaccine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5417986A (en) * 1984-03-16 1995-05-23 The United States Of America As Represented By The Secretary Of The Army Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
DE69016129T2 (en) * 1989-08-18 1995-05-24 Akzo Nobel Nv Vaccine against Escherichia coli.

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995029662A2 (en) * 1994-04-20 1995-11-09 U.S. Department Of The Army Vaccine against gram-negative bacterial infections
WO1996025146A1 (en) * 1995-02-16 1996-08-22 Novavax, Inc. Gram negative bacterial infection vaccine

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LUGOWSKI CZESLAW ET AL: "Anti-endotoxin antibodies directed against Escherichia coli R-1 oligosaccharide core-tetanus toxoid conjugate bind to smooth, live bacteria and smooth lipopolysaccharides and attenuate their tumor necrosis factor stimulating activity.", FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, vol. 16, no. 1, 1996, pages 31 - 38, XP002243177, ISSN: 0928-8244 *
See also references of WO9851217A1 *

Also Published As

Publication number Publication date
CA2289760A1 (en) 1998-11-19
EP1011440A1 (en) 2000-06-28
WO1998051217A1 (en) 1998-11-19
JP2001527562A (en) 2001-12-25
AU7491298A (en) 1998-12-08

Similar Documents

Publication Publication Date Title
GB9712347D0 (en) Vaccine
GB9718901D0 (en) Vaccine
GB9727262D0 (en) Vaccine
GB9711990D0 (en) Vaccine
GB9726555D0 (en) Vaccine
GB9720585D0 (en) Vaccine
GB9620795D0 (en) Vaccines
HUP9801901A3 (en) Turbogenerator
EP0958373A4 (en) Vaccines
GB9626864D0 (en) Vaccine
GB9611673D0 (en) Meningococcal vaccine
EP1011440A4 (en) Vaccine against lipopolysaccharide core
GB9721292D0 (en) Plug pull
ZA982763B (en) Vaccines
AU2002301930A1 (en) Vaccine against lipopolysaccharide core
GB9726147D0 (en) Antigens
ZA957482B (en) Vaccine
GB9814470D0 (en) Parasite vaccine
GB2322845A9 (en) Winding device
GB9419969D0 (en) Vaccine
GB9609252D0 (en) Vaccines
GB9718902D0 (en) Vaccine
GB9717423D0 (en) Vaccine
GB9720982D0 (en) Vaccine
AU128705S (en) Pillow core

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19991216

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): BE CH DE DK ES FR GB GR IE IT LI NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20030623

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060704